School of Medicine
Showing 441-460 of 578 Results
-
Bruce Arnow, Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsCurrent research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.
-
Katherine Arnow, MS
Biostatistician 3, Stanford-Surgery Policy Improvement Research and Education Center
BioKate is the senior biostatistician at the Stanford-Surgery Policy Improvement and Education Center in the Department of Surgery. Kate's degree is in epidemiology and she has a background in research and public health. Her research interests include surgical outcomes and health policy assessment.
-
Martijn Arns
Affiliate, Psychiatry and Behavioral Sciences
BioMartijn Arns, PhD, is an applied neuroscientist and entrepreneur with a longstanding focus on brain stimulation, neurofeedback/BCI, and medtech innovation, affiliated with the Stanford Brain Stimulation Lab and the Psychedelics and Consciousness Lab previously headed by Dr. Nolan Williams, dividing his time between Palo Alto and Nijmegen, the Netherlands.
In 2001, he founded the Brainclinics Foundation, a non-profit research institute dedicated to applied neuroscience from the clinic, to the clinic. His research and clinical work span interventional psychiatry, precision and stratified psychiatry, and novel interventions including rTMS for depression and OCD, TMS-induced Heart–Brain Coupling, neurofeedback, and psychedelics.
Dr. Arns has published over 190 scientific papers and holds four patents. He has successfully translated research into practice through multiple spin-off ventures. Beyond research and entrepreneurship, Dr. Arns contributes to the scientific community as associate editor for leading journals, organizer of international conferences, and board member of several professional organizations. He also advises medtech and AI start-ups and established companies, helping to advance translation and implementation in applied neuroscience. -
Lucia Aronica
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Lucia Aronica is a Lecturer at Stanford University School of Medicine with nearly two decades of research experience in epigenetics and nutrigenomics. She created Stanford's first courses in nutritional epigenetics and longevity medicine, and developed "epinutrition," a framework for using food to support healthy gene expression
Featured in the 2024 Netflix documentary "You Are What You Eat: A Twin Experiment," Dr. Aronica is a TEDx speaker who presents to 10,000+ clinicians annually. She has published 25+ peer-reviewed papers in top journals including Cell and BMC Medicine, and secured over $1 million in competitive research funding.
Dr. Aronica received her PhD in epigenetics from the University of Vienna (2010) and conducted research at Oxford and USC. She serves on scientific advisory boards in precision health and longevity medicine. -
Jason Arora MD, MPH, MA
Visiting Scholar, Epidemiology and Population Health
BioDr. Jason Arora is a Visiting Scholar at the Department of Epidemiology & Population Health at Stanford University School of Medicine, where he focuses on the development and deployment of AI applications in population health.
He holds degrees in Medicine and Medical Sciences from Oxford University and in Public Health from Harvard University, and is a former NHS physician, Fulbright Scholar, and Aspen Institute Health Fellow.
Dr. Arora has spent nearly two decades building and leading innovation efforts across healthcare, population health, and life sciences at some of the world's leading companies, including Google Life Sciences (Head of Clinical Science Innovation and Medical Affairs), Medtronic (Director of Value-Based Care), The Gates Foundation (AI Strategy Lead, Global Health), and ICHOM (Director; a non-profit joint venture co-founded by BCG, The Karolinska Institutet, and Harvard Business School). He is an experienced senior operator with a track record of building and leading large global teams across disciplines and sectors - including health systems, care models and quality improvement, clinical trials, digital health and AI, payment models, policy and regulation, medical devices, consumer health, and biotechnology.
Recognized as a Forbes 30 Under 30 lister in Healthcare and Science, and as a recipient of the Harvard Public Health Alumni Innovator Award and Lord Mayor of London & Guild of Freemen National Prize, Dr. Arora continues to serve as a judge for the Zayed Sustainability Prize administered by the Government of Abu Dhabi, and was previously a judge for Harvard’s Public Health Alumni Awards and an Honorary Fellow of The Royal Society of Arts.
He is a frequent keynote speaker and his work and commentary have appeared in top-tier journals and media, including the New England Journal of Medicine, Harvard Business Review, British Medical Journal, The Economist, Forbes, and the Journal of the American College of Cardiology. -
Parth Arora
Life Science Research Professional 1, Pediatrics - Pulmonary Medicine
BioParth is joining the School of Medicine as a Life Science Research Professional for the Department of Pediatrics. As a part of Dr. Christin Kuo’s Lab, Parth is driven to support the team’s mission and actively contribute to the intellectual environment of the lab. He recently graduated from the University of Illinois Chicago with a B.S. in Molecular and Cellular Biology. During his time at UIC, he has been a part of several research projects where he collaborated with Dr. Rhonda D. Kineman to design a research project to investigate variations in hepatic gene expression throughout the phases of the estrus cycle and study the impact of sexual dimorphism in the progression of the nonalcoholic fatty liver. He believes this position would be an excellent opportunity for him to apply his skills while engaging in multidisciplinary projects that would make a real-life impact. He is thrilled to receive this opportunity and looks forward to being a part of the Stanford Community.
-
Anna Chen Arroyo, MD MPH
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioAnna Chen Arroyo, MD, MPH, is a board-certified allergy/immunology physician and clinical researcher. She is the section chief of Allergy, Asthma, and Immunodeficiency in the Division of Pulmonary, Allergy and Critical Care Medicine and the medical director of the Allergy, Asthma, and Immunodeficiency Clinic at Stanford Health Care. She specializes in diagnosing and treating allergic conditions, with a focus on severe asthma, maternal asthma, and drug (including chemotherapy) allergies.
Dr. Arroyo’s clinical research focuses on early life risk factors for allergic disease development and how allergic diseases impact people across the lifespan. She is also interested in studying how allergic diseases affect the Asian American population and hormonal influences on allergic diseases. She has published her original research in peer-reviewed scientific journals, such as The Journal of Allergy and Clinical Immunology: In Practice and The Journal of the American Medical Association (JAMA). She has also presented at national conferences, including annual meetings for the American Thoracic Society and the American Academy of Asthma, Allergy, and Immunology. Dr. Arroyo is a member of the American Academy of Asthma, Allergy, and Immunology, the American Thoracic Society, and the American College of Allergy, Asthma, and Immunology. -
Peter Arsanyous
Visiting Postdoctoral Scholar, Adult Neurology
BioPeter Arsanyous is a Visiting Postdoctoral Research Scholar in the Department of Neurology at Stanford University. He is an ECFMG-certified physician with prior clinical experience in neurology and a strong interest in stroke mechanisms, neuroimaging, and outcomes research.
His current work centers on stroke-related clinical research, including imaging-based evaluation, acute stroke workflows, and secondary prevention. He is particularly interested in the integration of advanced neuroimaging and clinical decision-making in ischemic stroke care.
Dr. Arsanyous earned his medical degree from Misr University for Science and Technology (MUST) in Egypt. He has clinical training in neurology and internal medicine and maintains a strong interest in cerebrovascular diseases and the neurobiology of epilepsy.
His research interests align with Stanford’s acute stroke and reperfusion research, particularly the use of advanced neuroimaging to guide treatment decisions, optimize patient selection, and improve functional outcomes in ischemic stroke. He is motivated to contribute to clinical research initiatives and multicenter studies in stroke neurology. -
Maja Artandi, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Artandi is a Professor of Medicine in the Division of Primary Care and Population Health at Stanford. She is a leader in Primary Care, spearheading novel methods of health care delivery and education. She offers an impressive clinical background and has received several educational and leadership awards.
Her expertise lies in the development and implementation of a medical curriculum focused on the patient-physician interaction, emphasizing communication skills, physical examination skills and medical decision making to support best clinical practices.
Dr. Artandi is a dedicated Primary Care physician and educator and has served as a mentor for many students, residents and colleagues. She is currently the mentorship lead for the Division of Primary Care and Population Health.
She is in the process of getting an executive coaching certification and is faculty for the Advancing Communication Excellence at Stanford Program with the goal of helping her colleagues improve their communication skills.
From 2013-2021 she was the Co-Director of Primary Care education for the Stanford Internal Medicine residency program and co-founded and co-directed the Primary Care program (ACE) within the Stanford Internal Medicine Residency program.
Dr. Artandi is currently the Co-President of the Society of Bedside Medicine, an international society dedicated to studying and improving the patient/physician interaction.
She is a fellow of the Royal College of Physicians Edinburgh and of the American College of Physicians and currently serves as the Wellness chair for the Northern California ACP chapter. -
Steven Artandi, MD, PhD
Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.